Used in the research and development of treatments for neurodegenerative diseases, particularly Alzheimer’s disease. Targets tau protein aggregates in the brain, which are associated with disease progression. Helps in detecting and quantifying pathological tau in preclinical and clinical studies. Supports imaging and therapeutic strategies aimed at reducing tau burden and slowing cognitive decline. Investigated in clinical trials to evaluate its potential to modify disease course in patients with tauopathies.